Lee's academic research is aimed at helping patients expedite passage of urinary stones, a disease affecting more than 12% of men and 6% of women in the US alone. His company, Recon Therapeutics, allows powdered biotech drugs to be automatically mixed within a syringe using a pressurized water chamber. It is funded by $70,000 of non-dilutive grants and student awards.